Proteomic analysis revealed the survival strategy of Coxiella burnetii to doxycycline exposure

J Proteomics. 2019 Sep 30:208:103479. doi: 10.1016/j.jprot.2019.103479. Epub 2019 Aug 5.

Abstract

Antibiotic resistance is a global threat with a top concern in healthcare. Doxycycline is an antibiotic highly permeable to cell membrane used for treating a broad variety of bacteria, including Coxiella burnetii. This intracellular pathogen is the causative agent of Q fever, a re-emerging zoonosis found worldwide. Hence, C. burnetii has a considerable impact on the farming industry and public health, it is essential to explore its antibiotic adaptation/tolerance strategy to ensure effective therapy. Herein, we tracked changes in the bacterium induced by doxycycline exposure. Our proteomic analysis detected fifteen significantly altered proteins. Adjustments of some key proteins were verified by gene expression analysis. We also observed an increasing in hydrogen peroxide as a consequence of treatment, indicating deregulation of redox balance. Thus, our data suggests the reduction of protein synthesis to minimal levels, activation of the defense mechanism against oxidative stress and maintenance of cell envelope integrity as the key processes ensuring C. burnetii survival under doxycycline exposure. SIGNIFICANCE: Infection by intracellular microorganisms like C. burnetii requires long periods of treatment, thus antibiotic resistance development is a risk. In this report, 2-DE quantitative proteomics was used to identify changes in the proteome that occurs when C. burnetii is exposed to high concentrations of doxycycline. The identification of pathways impacted by doxycycline could be helpful to understand the mechanism of how C. burnetii is dealing with antibiotic stress.

Keywords: Axenic medium; Cell envelope homeostasis; Coxiella burnetii; Doxycycline; Proteomics; ROS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Coxiella burnetii / metabolism*
  • Doxycycline / pharmacology*
  • Drug Resistance, Bacterial / drug effects*
  • Microbial Viability / drug effects*
  • Proteomics

Substances

  • Doxycycline